

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, classical pathway (GO:0006958) | 9.82976165 |
| 2 | complement activation (GO:0006956) | 7.68880398 |
| 3 | positive regulation of respiratory burst (GO:0060267) | 6.91523666 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.67550515 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.09433564 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.07223611 |
| 7 | glomerular filtration (GO:0003094) | 5.63751729 |
| 8 | protein activation cascade (GO:0072376) | 5.53662808 |
| 9 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.45208421 |
| 10 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.26812222 |
| 11 | renal filtration (GO:0097205) | 5.01863025 |
| 12 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 4.91528687 |
| 13 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 4.91528687 |
| 14 | Fc-gamma receptor signaling pathway (GO:0038094) | 4.91528687 |
| 15 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 4.87926613 |
| 16 | regulation of antigen processing and presentation (GO:0002577) | 4.83952533 |
| 17 | humoral immune response (GO:0006959) | 4.76391356 |
| 18 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.64934425 |
| 19 | response to hepatocyte growth factor (GO:0035728) | 4.64934425 |
| 20 | positive regulation of antigen processing and presentation (GO:0002579) | 4.62588923 |
| 21 | regulation of respiratory burst (GO:0060263) | 4.60195154 |
| 22 | detection of bacterium (GO:0016045) | 4.59065197 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 4.54464139 |
| 24 | antibacterial humoral response (GO:0019731) | 4.35487978 |
| 25 | detection of other organism (GO:0098543) | 4.35146232 |
| 26 | antimicrobial humoral response (GO:0019730) | 4.32723524 |
| 27 | positive regulation of DNA biosynthetic process (GO:2000573) | 4.24878195 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.24288676 |
| 29 | regulation of cellular extravasation (GO:0002691) | 4.08726287 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04225750 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.96841883 |
| 32 | respiratory burst (GO:0045730) | 3.89431190 |
| 33 | retina homeostasis (GO:0001895) | 3.87804113 |
| 34 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.80743428 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.79854385 |
| 36 | B cell mediated immunity (GO:0019724) | 3.70131968 |
| 37 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.67228575 |
| 38 | cellular response to type I interferon (GO:0071357) | 3.62226053 |
| 39 | type I interferon signaling pathway (GO:0060337) | 3.62226053 |
| 40 | response to type I interferon (GO:0034340) | 3.59032054 |
| 41 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.57978617 |
| 42 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.53914353 |
| 43 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.52265837 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.47590707 |
| 45 | production of molecular mediator of immune response (GO:0002440) | 3.45992055 |
| 46 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.39564673 |
| 47 | positive thymic T cell selection (GO:0045059) | 3.38672116 |
| 48 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.28472846 |
| 49 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.24244056 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 3.22006548 |
| 51 | defense response to protozoan (GO:0042832) | 3.08339383 |
| 52 | cellular response to interferon-gamma (GO:0071346) | 3.07915234 |
| 53 | detection of external biotic stimulus (GO:0098581) | 3.07381756 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.07131765 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.07131765 |
| 56 | regulation of germinal center formation (GO:0002634) | 3.06503993 |
| 57 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.06359439 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04487463 |
| 59 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.00421269 |
| 60 | negative T cell selection (GO:0043383) | 2.99580545 |
| 61 | embryonic process involved in female pregnancy (GO:0060136) | 2.98853783 |
| 62 | T cell costimulation (GO:0031295) | 2.98088626 |
| 63 | lymphocyte costimulation (GO:0031294) | 2.93539371 |
| 64 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.93171825 |
| 65 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.92020917 |
| 66 | GDP-mannose metabolic process (GO:0019673) | 2.89170966 |
| 67 | reactive oxygen species biosynthetic process (GO:1903409) | 2.88535980 |
| 68 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.88432368 |
| 69 | lymph node development (GO:0048535) | 2.87404114 |
| 70 | immune response-activating signal transduction (GO:0002757) | 2.86700572 |
| 71 | negative thymic T cell selection (GO:0045060) | 2.85793070 |
| 72 | myeloid dendritic cell differentiation (GO:0043011) | 2.85237252 |
| 73 | B cell homeostasis (GO:0001782) | 2.83962360 |
| 74 | response to interferon-gamma (GO:0034341) | 2.82377891 |
| 75 | positive regulation of type 2 immune response (GO:0002830) | 2.79106763 |
| 76 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.77443319 |
| 77 | activation of immune response (GO:0002253) | 2.76180368 |
| 78 | positive T cell selection (GO:0043368) | 2.75873501 |
| 79 | germinal center formation (GO:0002467) | 2.74300412 |
| 80 | positive regulation of neutrophil migration (GO:1902624) | 2.74247045 |
| 81 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.74247045 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 2.73941986 |
| 83 | superoxide anion generation (GO:0042554) | 2.70945391 |
| 84 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.70757279 |
| 85 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.70386922 |
| 86 | positive regulation of immunoglobulin production (GO:0002639) | 2.70257654 |
| 87 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.69754740 |
| 88 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.67954800 |
| 89 | T cell selection (GO:0045058) | 2.67174259 |
| 90 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.64726330 |
| 91 | epithelial structure maintenance (GO:0010669) | 2.64165612 |
| 92 | defense response to Gram-negative bacterium (GO:0050829) | 2.63839725 |
| 93 | protein-chromophore linkage (GO:0018298) | 2.61948339 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60720886 |
| 95 | thymic T cell selection (GO:0045061) | 2.60085490 |
| 96 | positive regulation of interferon-alpha production (GO:0032727) | 2.58206978 |
| 97 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.57023369 |
| 98 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.56952648 |
| 99 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.54009121 |
| 100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.53481018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.62096172 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.98249820 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.64437828 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.40416145 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.18979953 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.09730747 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.00226799 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94712370 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.71096763 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.65914558 |
| 11 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.53457789 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51485484 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.35085754 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35031507 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.32784770 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31408218 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.27335550 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15983768 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10410159 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.09043070 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.08745297 |
| 22 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08231471 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03865339 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99437939 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.97281520 |
| 26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.94662901 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.94569699 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84905601 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.79090715 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76565158 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74536282 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73788674 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71112010 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67541765 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65902668 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63040880 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.62460061 |
| 38 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.59360770 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55627123 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54235082 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53585650 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53310187 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50820151 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49999560 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.49859712 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49064231 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.48149807 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44993151 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44044580 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42358592 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40783437 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40279688 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39243607 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34288172 |
| 55 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33944221 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32239769 |
| 57 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.30833037 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28899481 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.27897846 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27272393 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.22009823 |
| 62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19289552 |
| 63 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16406545 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16286373 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13714328 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13437849 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11304510 |
| 68 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10908645 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10789235 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09000789 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08956123 |
| 72 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08599347 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08249555 |
| 74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07418154 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07119325 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06402437 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06265066 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05301506 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04627166 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03994394 |
| 81 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03902782 |
| 82 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02914328 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02203566 |
| 84 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01162835 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00457261 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98195349 |
| 87 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97935505 |
| 88 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.96845088 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93845773 |
| 90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93112346 |
| 91 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91769210 |
| 92 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90452241 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90147184 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89287223 |
| 95 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.88894396 |
| 96 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88868994 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88745148 |
| 98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88021898 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87994437 |
| 100 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.85937274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001790_abnormal_immune_system | 3.73081390 |
| 2 | MP0005387_immune_system_phenotype | 3.73081390 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.56154325 |
| 4 | MP0003724_increased_susceptibility_to | 3.32935408 |
| 5 | MP0001800_abnormal_humoral_immune | 3.24434836 |
| 6 | MP0003303_peritoneal_inflammation | 3.15653449 |
| 7 | MP0000566_synostosis | 2.88286591 |
| 8 | MP0000685_abnormal_immune_system | 2.79153337 |
| 9 | MP0003436_decreased_susceptibility_to | 2.71883223 |
| 10 | MP0010155_abnormal_intestine_physiology | 2.68505060 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.64294970 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.51913182 |
| 13 | MP0005025_abnormal_response_to | 2.48711878 |
| 14 | MP0005671_abnormal_response_to | 2.45529331 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.38504974 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.29469901 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.29178816 |
| 18 | MP0002723_abnormal_immune_serum | 2.27239466 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.26072419 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.25602105 |
| 21 | MP0001819_abnormal_immune_cell | 2.25138510 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.15505620 |
| 23 | MP0009785_altered_susceptibility_to | 2.14057711 |
| 24 | MP0001958_emphysema | 2.09238322 |
| 25 | MP0008004_abnormal_stomach_pH | 1.99528281 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.96106238 |
| 27 | MP0005166_decreased_susceptibility_to | 1.95042624 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.89692967 |
| 29 | MP0002419_abnormal_innate_immunity | 1.85430202 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.82606285 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.81016852 |
| 32 | MP0003866_abnormal_defecation | 1.80831601 |
| 33 | MP0001873_stomach_inflammation | 1.77433508 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.76963786 |
| 35 | MP0005310_abnormal_salivary_gland | 1.76332408 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.70094992 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.69229381 |
| 38 | MP0002398_abnormal_bone_marrow | 1.67468241 |
| 39 | MP0000716_abnormal_immune_system | 1.67197129 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.67124278 |
| 41 | MP0006082_CNS_inflammation | 1.64070804 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.57856450 |
| 43 | MP0004947_skin_inflammation | 1.57180696 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.56457777 |
| 45 | MP0010352_gastrointestinal_tract_polyps | 1.55046441 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.46060423 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.43491683 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.41792949 |
| 49 | MP0004264_abnormal_extraembryonic_tissu | 1.40980502 |
| 50 | MP0005275_abnormal_skin_tensile | 1.40038010 |
| 51 | MP0000490_abnormal_crypts_of | 1.39498940 |
| 52 | MP0002429_abnormal_blood_cell | 1.38945833 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.33673399 |
| 54 | MP0002405_respiratory_system_inflammati | 1.31080663 |
| 55 | MP0002006_tumorigenesis | 1.27588876 |
| 56 | MP0002722_abnormal_immune_system | 1.25312205 |
| 57 | MP0002796_impaired_skin_barrier | 1.17437596 |
| 58 | MP0001849_ear_inflammation | 1.17044075 |
| 59 | MP0001663_abnormal_digestive_system | 1.12058964 |
| 60 | MP0003075_altered_response_to | 1.10456877 |
| 61 | MP0008469_abnormal_protein_level | 1.07494189 |
| 62 | MP0005381_digestive/alimentary_phenotyp | 1.05788577 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.02715447 |
| 64 | MP0000858_altered_metastatic_potential | 0.98363569 |
| 65 | MP0000477_abnormal_intestine_morphology | 0.94477811 |
| 66 | MP0003448_altered_tumor_morphology | 0.94182516 |
| 67 | MP0008438_abnormal_cutaneous_collagen | 0.93874641 |
| 68 | MP0001851_eye_inflammation | 0.93665413 |
| 69 | MP0002998_abnormal_bone_remodeling | 0.92295387 |
| 70 | MP0000343_altered_response_to | 0.92255089 |
| 71 | MP0000681_abnormal_thyroid_gland | 0.88925292 |
| 72 | MP0000703_abnormal_thymus_morphology | 0.88811166 |
| 73 | MP0005451_abnormal_body_composition | 0.87535651 |
| 74 | MP0005023_abnormal_wound_healing | 0.87119432 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 0.86293386 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.85618690 |
| 77 | MP0001764_abnormal_homeostasis | 0.84974314 |
| 78 | MP0005390_skeleton_phenotype | 0.80928345 |
| 79 | MP0002933_joint_inflammation | 0.80869158 |
| 80 | MP0010307_abnormal_tumor_latency | 0.78887972 |
| 81 | MP0003045_fibrosis | 0.77870012 |
| 82 | MP0000462_abnormal_digestive_system | 0.77816176 |
| 83 | MP0004858_abnormal_nervous_system | 0.77615786 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.76465071 |
| 85 | MP0005388_respiratory_system_phenotype | 0.76381728 |
| 86 | MP0002133_abnormal_respiratory_system | 0.76381728 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75963666 |
| 88 | MP0001853_heart_inflammation | 0.75060070 |
| 89 | MP0009840_abnormal_foam_cell | 0.72817229 |
| 90 | MP0001666_abnormal_nutrient_absorption | 0.69042959 |
| 91 | MP0005503_abnormal_tendon_morphology | 0.68562673 |
| 92 | MP0009764_decreased_sensitivity_to | 0.67862143 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.67334063 |
| 94 | MP0000249_abnormal_blood_vessel | 0.66973116 |
| 95 | MP0005085_abnormal_gallbladder_physiolo | 0.65753356 |
| 96 | MP0002060_abnormal_skin_morphology | 0.65106937 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.63543211 |
| 98 | MP0003795_abnormal_bone_structure | 0.63327261 |
| 99 | MP0002009_preneoplasia | 0.62276090 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.61332951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.28238680 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.63253606 |
| 3 | Recurrent bronchitis (HP:0002837) | 5.03798746 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.82361322 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.67787576 |
| 6 | Cellulitis (HP:0100658) | 4.48161260 |
| 7 | Meningitis (HP:0001287) | 4.08783170 |
| 8 | Recurrent pneumonia (HP:0006532) | 3.75885413 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.75068526 |
| 10 | Gastrointestinal stroma tumor (HP:0100723) | 3.71526065 |
| 11 | Xerostomia (HP:0000217) | 3.64113257 |
| 12 | Osteomyelitis (HP:0002754) | 3.56383286 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52280516 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.51877669 |
| 15 | Vasculitis (HP:0002633) | 3.46926209 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.45504140 |
| 17 | Prostate neoplasm (HP:0100787) | 3.41740892 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.38256897 |
| 19 | Obstructive lung disease (HP:0006536) | 3.38256897 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.27817693 |
| 21 | Colitis (HP:0002583) | 3.27228931 |
| 22 | Broad face (HP:0000283) | 3.26645887 |
| 23 | Chronic sinusitis (HP:0011109) | 3.24215229 |
| 24 | Verrucae (HP:0200043) | 3.22190493 |
| 25 | Papilloma (HP:0012740) | 3.22190493 |
| 26 | Inflammation of the large intestine (HP:0002037) | 3.21653509 |
| 27 | Skin rash (HP:0000988) | 3.16877572 |
| 28 | Recurrent lower respiratory tract infections (HP:0002783) | 3.16270370 |
| 29 | Bronchitis (HP:0012387) | 3.09649503 |
| 30 | Abnormality of the prostate (HP:0008775) | 3.09000853 |
| 31 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.06454113 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 3.03997951 |
| 33 | Urticaria (HP:0001025) | 3.03987354 |
| 34 | Cervical subluxation (HP:0003308) | 2.99566215 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.98460509 |
| 36 | Recurrent viral infections (HP:0004429) | 2.84353583 |
| 37 | Increased IgE level (HP:0003212) | 2.82463172 |
| 38 | Malnutrition (HP:0004395) | 2.81241980 |
| 39 | Gingivitis (HP:0000230) | 2.76781987 |
| 40 | Villous atrophy (HP:0011473) | 2.74903497 |
| 41 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.74903497 |
| 42 | Abnormality of the lumbar spine (HP:0100712) | 2.66772892 |
| 43 | Abnormality of complement system (HP:0005339) | 2.65329571 |
| 44 | Abnormality of incisor morphology (HP:0011063) | 2.62030220 |
| 45 | Sepsis (HP:0100806) | 2.60016099 |
| 46 | Recurrent skin infections (HP:0001581) | 2.55882016 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.53695367 |
| 48 | Increased IgM level (HP:0003496) | 2.49359245 |
| 49 | Abnormality of T cell physiology (HP:0011840) | 2.48352983 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43361736 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43361736 |
| 52 | J-shaped sella turcica (HP:0002680) | 2.43186963 |
| 53 | Recurrent otitis media (HP:0000403) | 2.43120284 |
| 54 | Neonatal short-limb short stature (HP:0008921) | 2.41624604 |
| 55 | Glomerulonephritis (HP:0000099) | 2.40178486 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 2.37973910 |
| 57 | Abnormality of B cell number (HP:0010975) | 2.37351642 |
| 58 | Complement deficiency (HP:0004431) | 2.36094014 |
| 59 | Restrictive lung disease (HP:0002091) | 2.35546213 |
| 60 | Skin ulcer (HP:0200042) | 2.34643017 |
| 61 | Emphysema (HP:0002097) | 2.32202119 |
| 62 | Recurrent sinusitis (HP:0011108) | 2.28587687 |
| 63 | Conical tooth (HP:0000698) | 2.25222571 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.25175128 |
| 65 | Hyperactive renin-angiotensin system (HP:0000841) | 2.24620255 |
| 66 | Hemorrhage of the eye (HP:0011885) | 2.20881577 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.19763971 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.18642741 |
| 69 | Nephritis (HP:0000123) | 2.18429451 |
| 70 | Abnormality of the costochondral junction (HP:0000919) | 2.17504597 |
| 71 | Abnormality of the peritoneum (HP:0002585) | 2.17386152 |
| 72 | Partial duplication of thumb phalanx (HP:0009944) | 2.17107534 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.13211070 |
| 74 | Lymphopenia (HP:0001888) | 2.12961160 |
| 75 | Leukocytosis (HP:0001974) | 2.11605091 |
| 76 | Premature loss of primary teeth (HP:0006323) | 2.08563111 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.03259690 |
| 78 | Dehydration (HP:0001944) | 2.02597590 |
| 79 | Abnormality of T cells (HP:0002843) | 2.02178042 |
| 80 | Encephalitis (HP:0002383) | 2.01277240 |
| 81 | Lymphoma (HP:0002665) | 1.99923680 |
| 82 | Chronic diarrhea (HP:0002028) | 1.99056878 |
| 83 | Hemoptysis (HP:0002105) | 1.97023233 |
| 84 | Granulocytopenia (HP:0001913) | 1.93030646 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 1.92687074 |
| 86 | Thickened helices (HP:0000391) | 1.92619515 |
| 87 | Hypermelanotic macule (HP:0001034) | 1.89021616 |
| 88 | Abnormality of primary teeth (HP:0006481) | 1.88258083 |
| 89 | B lymphocytopenia (HP:0010976) | 1.87444639 |
| 90 | Osteolytic defects of the hand bones (HP:0009699) | 1.87370177 |
| 91 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.87370177 |
| 92 | Abnormality of T cell number (HP:0011839) | 1.84940559 |
| 93 | Alopecia of scalp (HP:0002293) | 1.84907880 |
| 94 | Partial duplication of the phalanx of hand (HP:0009999) | 1.84630715 |
| 95 | Nasolacrimal duct obstruction (HP:0000579) | 1.84099855 |
| 96 | Mucopolysacchariduria (HP:0008155) | 1.83720260 |
| 97 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83720260 |
| 98 | Decreased circulating renin level (HP:0003351) | 1.82422893 |
| 99 | Hematochezia (HP:0002573) | 1.81263228 |
| 100 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80474772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.93682090 |
| 2 | IRAK4 | 3.61258481 |
| 3 | TYK2 | 3.60288283 |
| 4 | FGFR3 | 3.57290820 |
| 5 | MAP3K10 | 2.95979463 |
| 6 | GRK6 | 2.93508384 |
| 7 | BLK | 2.89690182 |
| 8 | PRPF4B | 2.86929376 |
| 9 | MST1R | 2.30224207 |
| 10 | KIT | 2.20274702 |
| 11 | IRAK3 | 2.08301939 |
| 12 | MAP4K1 | 2.04920939 |
| 13 | FGFR4 | 1.95091403 |
| 14 | BMPR2 | 1.86639758 |
| 15 | JAK1 | 1.80979461 |
| 16 | MAP3K14 | 1.80292578 |
| 17 | IKBKE | 1.72430846 |
| 18 | FES | 1.57857782 |
| 19 | ZAP70 | 1.55408887 |
| 20 | TBK1 | 1.53100669 |
| 21 | EPHA3 | 1.50264802 |
| 22 | TTN | 1.49608999 |
| 23 | RIPK4 | 1.48072691 |
| 24 | JAK3 | 1.47957187 |
| 25 | LYN | 1.47294227 |
| 26 | TAOK1 | 1.42824831 |
| 27 | TAOK2 | 1.36362967 |
| 28 | RIPK1 | 1.36295295 |
| 29 | PIM2 | 1.35979912 |
| 30 | DMPK | 1.35302632 |
| 31 | IKBKB | 1.32745661 |
| 32 | KDR | 1.28857837 |
| 33 | TESK2 | 1.26654441 |
| 34 | SIK3 | 1.24831528 |
| 35 | CDC42BPA | 1.23600520 |
| 36 | MAPK11 | 1.22655505 |
| 37 | MAP3K1 | 1.21515559 |
| 38 | PRKD2 | 1.18343261 |
| 39 | SYK | 1.17883060 |
| 40 | IRAK1 | 1.16335355 |
| 41 | JAK2 | 1.16124534 |
| 42 | TXK | 1.11358905 |
| 43 | MAP3K3 | 1.06585920 |
| 44 | ARAF | 1.02333969 |
| 45 | MAP2K3 | 0.99246665 |
| 46 | DAPK1 | 0.94878005 |
| 47 | PIK3CA | 0.94226194 |
| 48 | MAPKAPK2 | 0.91007275 |
| 49 | MAPK12 | 0.90787915 |
| 50 | CSK | 0.88704657 |
| 51 | LCK | 0.87972622 |
| 52 | MAP3K13 | 0.87584110 |
| 53 | BTK | 0.86107894 |
| 54 | EPHB1 | 0.84502242 |
| 55 | FYN | 0.83492834 |
| 56 | ILK | 0.79020649 |
| 57 | TRIB3 | 0.76521184 |
| 58 | TGFBR1 | 0.76408119 |
| 59 | LRRK2 | 0.69571876 |
| 60 | SIK1 | 0.67741150 |
| 61 | IRAK2 | 0.67452522 |
| 62 | MAP3K8 | 0.62967793 |
| 63 | PRKD1 | 0.61293144 |
| 64 | MAP3K11 | 0.58963551 |
| 65 | HCK | 0.58743679 |
| 66 | PIM1 | 0.58219597 |
| 67 | CSF1R | 0.56393812 |
| 68 | PRKCD | 0.55929554 |
| 69 | STK10 | 0.55568362 |
| 70 | ACVR1B | 0.54033147 |
| 71 | CDK4 | 0.52716197 |
| 72 | TGFBR2 | 0.52570842 |
| 73 | CAMK2D | 0.51933201 |
| 74 | MAPK4 | 0.51332612 |
| 75 | CAMK2B | 0.50692963 |
| 76 | PKN2 | 0.50402086 |
| 77 | MATK | 0.48459837 |
| 78 | PAK4 | 0.48194215 |
| 79 | CAMK2G | 0.47510525 |
| 80 | YES1 | 0.46632067 |
| 81 | ROCK2 | 0.45973140 |
| 82 | TESK1 | 0.45288906 |
| 83 | RAF1 | 0.44957060 |
| 84 | EIF2AK1 | 0.42787604 |
| 85 | FER | 0.41910426 |
| 86 | RPS6KC1 | 0.41086030 |
| 87 | RPS6KL1 | 0.41086030 |
| 88 | EPHB2 | 0.38490251 |
| 89 | STK38 | 0.37998371 |
| 90 | IGF1R | 0.37856345 |
| 91 | ICK | 0.37467095 |
| 92 | MAP2K2 | 0.36870901 |
| 93 | EPHA2 | 0.36690752 |
| 94 | STK24 | 0.34681948 |
| 95 | NLK | 0.33886426 |
| 96 | SCYL2 | 0.33263693 |
| 97 | RPS6KA2 | 0.32752914 |
| 98 | MAPK7 | 0.32549933 |
| 99 | MAP3K5 | 0.31689555 |
| 100 | FGFR1 | 0.31458895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.30628414 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.21325881 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.03182505 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.94637711 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.69399320 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.68181531 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.12208817 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90128195 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.81175298 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.60613951 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.41627250 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.39259714 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39034168 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.81984584 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70021122 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69636113 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.69397237 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.68364376 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.56049374 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52687646 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.43933504 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38309906 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36296036 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.34756234 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31927297 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.19489759 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19307342 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11886412 |
| 29 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.04897044 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.00885301 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.00761946 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97934714 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89735695 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89583876 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85486401 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82175268 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 0.81267787 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81084445 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80032312 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79984818 |
| 41 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79720208 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78819630 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75682544 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74783161 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73551871 |
| 46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73015625 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.72333894 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 0.71146776 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70293831 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68207570 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65803796 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65125010 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63307109 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63150836 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 0.61031813 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59936256 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58859603 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58080345 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56171439 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53428515 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.52138074 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.52132498 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.50812223 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49901457 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49469319 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47208116 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45864939 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45601459 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45440597 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45320413 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45102790 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.43946901 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43812326 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42697077 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40679902 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.39501198 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.38623376 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.36827559 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36508815 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33866201 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32910575 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32731500 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31318437 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.28491520 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28332636 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.27977096 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26699766 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26202814 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24937457 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22982830 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21724331 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21685392 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19637172 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.18215049 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.17685326 |
| 96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.16564033 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.16493585 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.16223770 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15058779 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.14684303 |

